Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 0363-0010-34), b.) 65 count bottles (NDC 0363-0010-61) , c.) 9
Recalled November 13, 2019 · FDA recall D-0170-2020 · Dr. Reddy's Laboratories
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product. · FDA Class II
Units
N/A
Sold at
Product was distributed to major distributors throughout the United States who may have further distributed the product.
Description
CGMP Deviations: Presence of NDMA impurity detected in product.
Product
Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 0363-0010-34), b.) 65 count bottles (NDC 0363-0010-61) , c.) 95 count bottles (NDC 0363-0010-62), d.) 200 count bottles (NDC 0363-0010-01) (Walgreens) OTC
Manufacturer(s)
Dr. Reddy's Laboratories, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →